Qi Wang1, Svetlana N Bozack1, Yuanqing Yan2, Michael E Boulton3, Maria B Grant3, Julia V Busik1. 1. Department of Physiology, Michigan State University, East Lansing, Michigan, United States. 2. Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida, United States. 3. Department of Pharmacology and Therapeutics, University of Florida, Gainesville, Florida, United States Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, Indiana, United States.
Abstract
PURPOSE: Chronic inflammation and dysregulation of circadian rhythmicity are involved in the pathogenesis of diabetic retinopathy. MicroRNAs (miRNAs) can regulate inflammation and circadian clock machinery. We tested the hypothesis that altered daily rhythm of miR-146a expression in diabetes contributes to retinal inflammation. METHODS: Nondiabetic and STZ-induced diabetic rats kept in 12/12 light/dark cycle were killed every 2 hours over a 72-hour period. Human retinal endothelial cells (HRECs) were synchronized with dexamethasone. Expression of miR-146a, IL-1 receptor-associated kinase 1 (IRAK1), IL-1β, VEGF and ICAM-1, as well as clock genes was examined by real-time PCR and Western blot. To modulate expression levels of miR-146a, mimics and inhibitors were used. RESULTS: Diabetes inhibited amplitude of negative arm (per1) and enhanced amplitude of the positive arm (bmal1) of clock machinery in retina. In addition to clock genes, miR-146a and its target gene IRAK1 also exhibited daily oscillations in antiphase; however, these patterns were lost in diabetic retina. This loss of rhythmic pattern was associated with an increase in ICAM-1, IL-β, and VEGF expression. Human retinal endothelial cells had robust miR-146a expression that followed circadian oscillation pattern; however, HRECs isolated from diabetic donors had reduced miR-146a amplitude but increased amplitude of IRAK1 and ICAM-1. In HRECs, miR-146a mimic or inhibitor caused 1.6- and 1.7-fold decrease or 1.5- and 1.6-fold increase, respectively, in mRNA and protein expression levels of ICAM-1 after 48 hours. CONCLUSIONS: Diabetes-induced dysregulation of daily rhythms of miR-146a and inflammatory pathways under miR-146a control have potential implications for the development of diabetic retinopathy. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
PURPOSE: Chronic inflammation and dysregulation of circadian rhythmicity are involved in the pathogenesis of diabetic retinopathy. MicroRNAs (miRNAs) can regulate inflammation and circadian clock machinery. We tested the hypothesis that altered daily rhythm of miR-146a expression in diabetes contributes to retinal inflammation. METHODS: Nondiabetic and STZ-induced diabeticrats kept in 12/12 light/dark cycle were killed every 2 hours over a 72-hour period. Human retinal endothelial cells (HRECs) were synchronized with dexamethasone. Expression of miR-146a, IL-1 receptor-associated kinase 1 (IRAK1), IL-1β, VEGF and ICAM-1, as well as clock genes was examined by real-time PCR and Western blot. To modulate expression levels of miR-146a, mimics and inhibitors were used. RESULTS:Diabetes inhibited amplitude of negative arm (per1) and enhanced amplitude of the positive arm (bmal1) of clock machinery in retina. In addition to clock genes, miR-146a and its target gene IRAK1 also exhibited daily oscillations in antiphase; however, these patterns were lost in diabetic retina. This loss of rhythmic pattern was associated with an increase in ICAM-1, IL-β, and VEGF expression. Human retinal endothelial cells had robust miR-146a expression that followed circadian oscillation pattern; however, HRECs isolated from diabetic donors had reduced miR-146a amplitude but increased amplitude of IRAK1 and ICAM-1. In HRECs, miR-146a mimic or inhibitor caused 1.6- and 1.7-fold decrease or 1.5- and 1.6-fold increase, respectively, in mRNA and protein expression levels of ICAM-1 after 48 hours. CONCLUSIONS:Diabetes-induced dysregulation of daily rhythms of miR-146a and inflammatory pathways under miR-146a control have potential implications for the development of diabetic retinopathy. Copyright 2014 The Association for Research in Vision and Ophthalmology, Inc.
Authors: Ruth A Akhtar; Akhilesh B Reddy; Elizabeth S Maywood; Jonathan D Clayton; Verdun M King; Andrew G Smith; Timothy W Gant; Michael H Hastings; Charalambos P Kyriacou Journal: Curr Biol Date: 2002-04-02 Impact factor: 10.834
Authors: Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore Journal: Proc Natl Acad Sci U S A Date: 2006-08-02 Impact factor: 11.205
Authors: M Balasubramanyam; S Aravind; K Gokulakrishnan; P Prabu; C Sathishkumar; H Ranjani; V Mohan Journal: Mol Cell Biochem Date: 2011-01-20 Impact factor: 3.396
Authors: Wigard P Kloosterman; Anne K Lagendijk; René F Ketting; Jon D Moulton; Ronald H A Plasterk Journal: PLoS Biol Date: 2007-08 Impact factor: 8.029
Authors: Maria Tikhonenko; Todd A Lydic; Yun Wang; Weiqin Chen; Madalina Opreanu; Andrew Sochacki; Kelly M McSorley; Rebecca L Renis; Timothy Kern; Donald B Jump; Gavin E Reid; Julia V Busik Journal: Diabetes Date: 2009-10-29 Impact factor: 9.461
Authors: Vincent A Funari; Michael Winkler; Jordan Brown; Slobodan D Dimitrijevich; Alexander V Ljubimov; Mehrnoosh Saghizadeh Journal: PLoS One Date: 2013-12-20 Impact factor: 3.240
Authors: Aicha Saadane; Natalia Mast; George Trichonas; Dibyendu Chakraborty; Sandra Hammer; Julia V Busik; Maria B Grant; Irina A Pikuleva Journal: Am J Pathol Date: 2018-11-16 Impact factor: 4.307